Modeling and Predicting Antibody Durability for mRNA-1273 Vaccine for SARS-CoV-2 Variants
View ORCID ProfileGeorge Luo, Zhongbo Hu, John J. Letterio
doi: https://doi.org/10.1101/2021.05.04.21256537
George Luo
1Case Comprehensive Cancer Center, Cleveland, Ohio, USA
Zhongbo Hu
1Case Comprehensive Cancer Center, Cleveland, Ohio, USA
2The Angie Fowler Adolescent & Young Adult Cancer Institute, University Hospitals Rainbow Babies & Children’s Hospital, Cleveland, Ohio, USA
John J. Letterio
1Case Comprehensive Cancer Center, Cleveland, Ohio, USA
2The Angie Fowler Adolescent & Young Adult Cancer Institute, University Hospitals Rainbow Babies & Children’s Hospital, Cleveland, Ohio, USA
Posted May 04, 2021.
Modeling and Predicting Antibody Durability for mRNA-1273 Vaccine for SARS-CoV-2 Variants
George Luo, Zhongbo Hu, John J. Letterio
medRxiv 2021.05.04.21256537; doi: https://doi.org/10.1101/2021.05.04.21256537
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (718)
- Anesthesia (210)
- Cardiovascular Medicine (3001)
- Dermatology (256)
- Emergency Medicine (448)
- Epidemiology (12896)
- Forensic Medicine (12)
- Gastroenterology (840)
- Genetic and Genomic Medicine (4697)
- Geriatric Medicine (432)
- Health Economics (741)
- Health Informatics (2984)
- Health Policy (1081)
- Hematology (399)
- HIV/AIDS (942)
- Medical Education (439)
- Medical Ethics (116)
- Nephrology (481)
- Neurology (4485)
- Nursing (239)
- Nutrition (657)
- Oncology (2328)
- Ophthalmology (659)
- Orthopedics (262)
- Otolaryngology (330)
- Pain Medicine (289)
- Palliative Medicine (85)
- Pathology (506)
- Pediatrics (1217)
- Primary Care Research (509)
- Public and Global Health (7069)
- Radiology and Imaging (1570)
- Respiratory Medicine (933)
- Rheumatology (454)
- Sports Medicine (390)
- Surgery (497)
- Toxicology (62)
- Transplantation (214)
- Urology (186)